NeurologyLive Peer Exchange

Expert neurologists discuss the impact of MS on the immune system and comment on the use of COVID-19 vaccines with MS treatment and the use of high efficacy therapies in MS.

Experts in movement disorders highlight the importance of patient and provider education around OFF episodes and share strategies for optimizing the management of OFF episodes in the Parkinson disease treatment landscape.

In this Peer Exchange special edition, Scott Newsome, DO, leads a discussion with Alberto Ascherio, MD, DrPH; Anne Cross, MD; Avindra Nath, MD; and Michael Racke, MD, about the practical and clinical implications of a recently published novel longitudinal study, the first of its kind to draw a causal link between Epstein-Barr Virus and multiple sclerosis.

Jessica Ailani, MD; Bradley Torphy, MD; Sait Ashina, MD; Andrew C. Charles, MD; and Julio R. Vieira, MD, share expert approaches to the diagnosis and treatment of acute and preventive migraine and discuss key insights on the evolving treatment landscape.

Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.

Recommendations to neurologists on appropriately prescribing and managing patients with relapsing-remitting multiple sclerosis using novel, oral therapies.

Expert neurologists provide a discussion on current treatment options for migraine and review data from recent clinical trials.

Experts discuss the causes, impact on quality of life, and the management of morning OFF episodes in Parkinson’s disease.

Recommendations for selecting and sequencing therapies used to treat patients with relapsing multiple sclerosis.

Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD explore several topics pertaining to the diagnosis and treatment of relapsing multiple sclerosis (MS), including current treatment options, therapy sequencing, and the future of MS management.